[go: up one dir, main page]

MX2012007393A - Composicion farmaceutica de disolucion rapida comprendiendo lornoxicam. - Google Patents

Composicion farmaceutica de disolucion rapida comprendiendo lornoxicam.

Info

Publication number
MX2012007393A
MX2012007393A MX2012007393A MX2012007393A MX2012007393A MX 2012007393 A MX2012007393 A MX 2012007393A MX 2012007393 A MX2012007393 A MX 2012007393A MX 2012007393 A MX2012007393 A MX 2012007393A MX 2012007393 A MX2012007393 A MX 2012007393A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
fast dissolving
lornoxicam
dissolving pharmaceutical
pharmaceutically acceptable
Prior art date
Application number
MX2012007393A
Other languages
English (en)
Inventor
Sanjay Boldhane
Kuldeep Bhokare
Shripad Dr Jathar
Geraldine Ann Elliott
Original Assignee
Abbott Healthcare Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Healthcare Private Ltd filed Critical Abbott Healthcare Private Ltd
Publication of MX2012007393A publication Critical patent/MX2012007393A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención describe una composición farmacéutica de disolución rápida comprendiendo lornoxicam o sales farmacéuticamente aceptables del mismo como un ingrediente activo junto con al menos un alcalinizador, por lo menos un ácido orgánico y al menos un excipiente farmacéuticamente aceptable. La presente invención también describe procesos de preparar composición farmacéutica de disolución rápida.
MX2012007393A 2009-12-24 2010-12-21 Composicion farmaceutica de disolucion rapida comprendiendo lornoxicam. MX2012007393A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2993MU2009 2009-12-24
PCT/IN2010/000832 WO2011077452A2 (en) 2009-12-24 2010-12-21 Fast dissolving pharmaceutical composition comprising lornoxicam

Publications (1)

Publication Number Publication Date
MX2012007393A true MX2012007393A (es) 2012-08-15

Family

ID=44196220

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012007393A MX2012007393A (es) 2009-12-24 2010-12-21 Composicion farmaceutica de disolucion rapida comprendiendo lornoxicam.

Country Status (6)

Country Link
US (1) US20130171254A1 (es)
EP (1) EP2515909A2 (es)
BR (1) BR112012015359A2 (es)
MX (1) MX2012007393A (es)
RU (1) RU2012131509A (es)
WO (1) WO2011077452A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013136346A2 (en) * 2012-03-15 2013-09-19 Katakam Venkatesh Taste masking pharmaceutical orally dissolving strips of lornoxicam
USD768634S1 (en) 2014-08-11 2016-10-11 Apple Inc. Backplate for electronic device
KR101721831B1 (ko) * 2014-11-06 2017-03-31 주식회사 종근당 로베글리타존을 함유하는 경구 투여용 약제학적 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040258740A1 (en) * 2003-04-10 2004-12-23 Nene Labs Transdermal delivery composition

Also Published As

Publication number Publication date
US20130171254A1 (en) 2013-07-04
WO2011077452A2 (en) 2011-06-30
WO2011077452A3 (en) 2011-10-06
BR112012015359A2 (pt) 2017-03-07
EP2515909A2 (en) 2012-10-31
RU2012131509A (ru) 2014-01-27

Similar Documents

Publication Publication Date Title
UA105229C2 (uk) Фармацевтичний склад
PH12015502628A1 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of disease
UA105042C2 (uk) Самомікроемульговувана оральна фармацевтична композиція гідрофільного лікарського засобу і спосіб її одержання
MX2015016344A (es) Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades.
HUE037742T2 (hu) Szubsztituált azolok, vírusellenes aktív adalék, gyógyszerészeti készítmény, az elõállításukat célzó eljárás és alkalmazásuk
AU2011274192A8 (en) Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof
CY1119798T1 (el) Μορφη iv υδροχλωρικης ιβαμπραδινης
ATE536172T1 (de) Ezetimibzusammensetzungen
TW201144301A (en) Processes for preparing linezolid
WO2013112959A8 (en) Antifibrotic compounds and uses thereof
EA201201202A1 (ru) Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана
MX2016003754A (es) Una composicion farmaceutica estable que contiene amlodipina y valsartan.
MY159251A (en) Processes for the manufacture of a pharmaceutically active agent
WO2011005052A8 (en) Novel arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same
WO2011135580A3 (en) Pharmaceutical compositions of sirolimus
MX2015007940A (es) Compuestos tricíclicos como inhibidores de cftr.
TN2014000060A1 (en) Benzothiazolone compound
JO3587B1 (ar) أشكال جرعات بينداموستين عن طريق الفم
WO2009133455A3 (en) Pharmaceutical composition of clodipogrel
WO2012085249A3 (en) Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts together with an organic acid
WO2012108631A3 (en) Pharmaceutical compositions comprising revaprazan-containing nanoparticles and processes for the preparation thereof
WO2011014003A3 (en) (+)-3-hydroxymorphinan derivatives as neuroprotectants
MX2012007393A (es) Composicion farmaceutica de disolucion rapida comprendiendo lornoxicam.
TR201803451T4 (tr) Olmesartan formülasyonlari.
TR201009399A2 (tr) Hızlı çözünen efervesan rosuvastatin formülasyonları.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal